Ipamorelin

Ipamorelin is a synthetic pentapeptide that acts as a highly selective agonist of the ghrelin/growth hormone secretagogue receptor. Preclinical studies indicate that Ipamorelin stimulates somatotropic release without elevating ACTH, cortisol, or prolactin levels.

“Ipamorelin represents the first selective somatotropic secretagogue that avoids cortisol and prolactin receptor pathways during experimental assays.”

You can review detailed clinical trials at ClinicalTrials.gov Ipamorelin Portal or search PubMed indexing at PubMed Ipamorelin Collection to evaluate its role in endocrinology and cell metabolism research. Its molecular structures are verified in the PubChem Ipamorelin Database.

Key Areas of Investigation:

• GHSR Selective Agonism: Evaluating pituitary ghrelin receptor binding and signal pathways.
• Pure Somatotropic Release: Studies on hormone pulses without stress hormone elevations.
• Gastrointestinal Motility: Preclinical research regarding GHS receptor activations in smooth muscles.

This material is supplied exclusively as a lyophilized solid for laboratory research and analytical evaluation, and is strictly not for human or therapeutic use.